Search clinical trials for: Placebo for BRII-196 BRII-198

Total 384 results

Brii Biosciences Limited
TSB Therapeutics (Beijing) CO.LTD

Completed

A Study of Human Monoclonal Antibodies, BRII-196 and BRII-198

COVID-19

China
Brii Biosciences Limited
TSB Therapeutics (Beijing) CO.LTD

Completed

A Phase 1 Study of Human Monoclonal Antibodies, BRII-196 and BRII-198

COVID-19

China
Brii Biosciences, Inc.

Withdrawn

A Safety and Efficacy Study of Human Monoclonal Antibodies, BRII-196 and BRII-198 for the Treatment of Patients With COVID-19

COVID-19

China
National Institute of Allergy and Infectious Diseases...
National Heart, Lung, and Blood Institute (NHLBI); University of Copenhagen; US... and other collaborators

Completed

BRII-196/BRII-198 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

COVID-19

United States, Denmark, Poland, Singapore, Spain, Switzerland, Uganda, United Kingdom
Brii Biosciences Limited
TSB Therapeutics (Beijing) CO.LTD

Completed

Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-196

COVID-19

China
Brii Biosciences Limited
TSB Therapeutics (Beijing) CO.LTD

Completed

Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-198

COVID-19

China
Brii Biosciences Limited

Completed

A Study of BRII-297 in Healthy Adult Subjects

Postpartum Depression

Australia
National Institute of Allergy and Infectious Diseases...
Eli Lilly and Company; National Heart, Lung, and Blood Institute (NHLBI); Gla... and other collaborators

Completed

ACTIV-3: Therapeutics for Inpatients With COVID-19 (TICO)

Covid19

United States, Denmark, Greece, Nigeria, Poland, Singapore, Spain, Switzerland, Uganda, United Kingdom
National Institute of Allergy and Infectious Diseases...
Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; AIDS Clinical Trials... and other collaborators

Completed

ACTIV-2: A Study for Outpatients With COVID-19

Covid19 | Coronavirus

United States, Argentina, Brazil, Guatemala, Mexico, Philippines, Puerto Rico, South Africa, Canada
Brii Biosciences Limited

Completed

A Study of BRII-296 in Adults With Severe Postpartum Depression (PPD)

Severe Postpartum Depression

United States
Boehringer Ingelheim

Terminated

Increasing Dose Tolerance Study in Healthy Male Volunteers After Administration of BIII 890 CL

Healthy
Boehringer Ingelheim

Completed

Safety and Tolerability of BIII 890 in Patients With Acute Ischemic Stroke

Stroke
Boehringer Ingelheim

Completed

Single Increasing Doses of BIII 890 CL in Healthy Young Male Volunteers and in Healthy Elderly Male and Female Volunteers

Healthy
Abbott Medical Devices

Completed

IPG Replacement Study (PREFERENCE-H) (PREFERENCE-H)

Parkinson Disease

Italy, Germany, United States
HeNan Sincere Biotech Co., Ltd

Completed

A Study of CL-197 Capsules in Healthy Participants

HIV-1

China
Sichuan Haisco Pharmaceutical Group Co., Ltd

Completed

Safety, Tolerability and Pharmacokinetics of FTP-198 in Healthy Australian Volunteers

Healthy

Australia
National Institute of Allergy and Infectious Diseases...

Completed

EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly in Semi-immune Adults

Plasmodium Falciparum Malaria

Ghana
National Institute of Allergy and Infectious Diseases...

Completed

H3N2 M2SR in Pediatric Population

Influenza | Influenza Immunisation

United States
National Cancer Institute (NCI)

Completed

Tivantinib in Treating Patients With Metastatic Prostate Cancer

Prostate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate Cancer

United States
Medical University of Vienna
Landesklinikum Sankt Polten; Sicknessfund Burgenland (BGKK); A.ö. Krankenhaus...

Completed

Health Status Prior and Post Infection With Influenza or COVID 19: a Population Based Retrospective Analysis of 2016-2021

Influenza | Covid 19
Mitsubishi Tanabe Pharma Corporation

Terminated

A Phase III, Multi-Centre, Randomised, Placebo-Controlled Study in Combination With Ca-based P Binders in Patients With Hyperphosphatemia

Chronic Kidney Disease | Hyperphosphatemia | Dialysis

France, Poland, Spain, Serbia, South Africa, Czech Republic, Germany, Macedonia, The Former Yugoslav Republic of, Italy, United Kingdom
University of California, San Francisco
University of California, Los Angeles

Completed

COVID-19 PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY) (PRIORITY)

COVID-19 | Pregnancy | Coronavirus

United States
Abbott

Completed

Pharmacokinetic Study of ABT-126 in Stable Subjects With Schizophrenia

Schizophrenia

United States
Daiichi Sankyo, Inc.
Medpace, Inc.

Completed

Effect of Tivantinib on the QTC Interval in Cancer Subjects

Solid Tumors

United States
ArQule, Inc. (a wholly owned subsidiary of Merck...

Completed

Trial of ARQ 197 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Who Have Failed One Prior Systemic Therapy

Unresectable Hepatocellular Carcinoma

Belgium, Italy, United States, Germany, Canada
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety Study of MCI-196 in Patients With Type 2 Diabetes

Type 2 Diabetes
Mitsubishi Tanabe Pharma Corporation

Completed

A Study of MCI-196 in Chronic Kidney Disease Subjects on Dialysis With Hyperphosphatemia and Dyslipidaemia

Dyslipidemia | Chronic Kidney Disease | Hyperphosphatemia | Dialysis

Poland, Ukraine, Serbia, Russian Federation, Hungary, Malaysia, Italy, Macedonia, The Former Yugoslav Republic of
Vienna Hospital Association

Recruiting

The Mamma HiToP Study

Chemotherapy-induced Peripheral Neuropathy

Austria
Mitsubishi Tanabe Pharma Corporation

Completed

A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia

Chronic Kidney Disease | Hyperphosphatemia | Dialysis

United States, Puerto Rico
Dermama Bioteknologi Laboratorium
Kementerian Riset dan Teknologi / Badan Riset dan Inovasi Nasional, Indonesia

Recruiting

Efficacy and Safety of EXOSOME-MSC Therapy to Reduce Hyper-inflammation In Moderate COVID-19 Patients (EXOMSC-COV19)

SARS-CoV2 Infection

Indonesia
Methodist Health System

Recruiting

Methodist Health System COVID-19 Patient Registry

COVID-19

United States
Kanuni Sultan Suleyman Training and Research Hospital

Completed

Possible Predictors of Mortality Based on COVID-19 for Patients Under 50 Years Old: A Multi-Center Experience of Istanbul

Covid-19 | Risk Factor, Mortality

Turkey
Universitaire Ziekenhuizen KU Leuven
Ziekenhuis Oost-Limburg

Completed

The Use of a Morcellator in Operative Hysteroscopy for Benign Intracavitary Lesions: a Feasibility Study

Myoma;Uterus | Retained Products of Conception | Endometrial Polyp Benign

Belgium
Assiut University

Completed

Effect Not Imposing COVID-19 Testing Prior to Elective Cataract Surgery

COVID-19 | Cataract Surgery

Egypt
Baker Heart and Diabetes Institute

Completed

Sympathetic Nervous System Inhibition for the Treatment of Diabetic Kidney Disease

Diabetic Nephropathies

Australia
Cairo University

Completed

Association Between Periodontitis and Coronavirus Disease (COVID-19)

Periodontitis

Egypt
Hôpital Européen Marseille

Unknown

Prevalence of COVID-19 Infection in a Cohort of Patients Infected by the HIV and Patients Taking PrEP

Covid19 | Virus-HIV

France
Hospital St. Joseph, Marseille, France

Unknown

Registry of the Evolution of Diagnosed and/or Hospitalized Patients for Pulmonary Embolism During the Covid-19 Pandemic (COVID-EP)

Pulmonary Embolism

France
Genexine, Inc.
PT Kalbe Farma Tbk

Withdrawn

Evaluation of Efficacy, Safety and Immunogenicity of GX-19N in Healthy Individuals Who Have Received COVID-19 Vaccines

SARS-CoV2 Infection
Boehringer Ingelheim

Completed

Assess the Efficacy and Tolerability of Antistax Film-coated Tablets in Patients With Chronic Venous Insufficiency

Venous Insufficiency

Germany
Centre Hospitalier Intercommunal Creteil

Completed

Perceptions, Representations and Experiences of Septic Isolation of Hospitalized Patients for COVID-19 Infection

COVID19

France
Linkoeping University
Region Östergötland

Active, not recruiting

Characteristics and Outcomes of Patients Admitted to Swedish Intensive Care Units for COVID-19

COVID-19 | Critical Illness

Sweden
Rigshospitalet, Denmark

Completed

Optimal Length for Nasal Mid-turbinate and Nasopharyngeal Swabs

Covid19

Denmark
E25Bio, Inc.
SCRI Development Innovations, LLC

Completed

A Clinical Evaluation of COVID-19 Rapid Point of Care Antigen Tests

SARS CoV-2

United States
Hadassah Medical Organization
London North West Healthcare NHS Trust

Not yet recruiting

Severe COVID-19 Infection in Children Presenting to EDs in Israel and England (SPICE)

COVID-19 | Inflammatory Response
Forman Christian College, Pakistan
King Edward Medical University

Completed

Nurse Leadership for Hospital Infection Control

Infection | Nurse's Role

Pakistan
xCures
Cancer Commons; Genetic Alliance; LunaDNA; REDCap Cloud

Completed

Behavior, Environment And Treatments for Covid-19 (BEAT19)

Coronavirus

United States
Scripps Translational Science Institute
Cue Health

Active, not recruiting

ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals

HIV Infections | Lymphoma | Leukemia | Cancer | Multiple Myeloma | Immunosuppression | Immunodeficiency | Transplant | Graft Versus Host Disease | Age-Related Immunodeficiency

United States
University of New Mexico
National Institutes of Health (NIH); National Institute of General Medical...

Completed

The Role of Frequent Point-of-care Molecular Workplace Surveillance for Miners

Covid19

United States
University of Toronto

Completed

#SafeHandsSafeHearts: An eHealth Intervention for COVID-19 Prevention and Support (COVID-19)

Covid19

Canada, India, Thailand

Search clinical trials for: Placebo for BRII-196 BRII-198

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Armenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations